您当前的位置:
首页 >
文章列表页 >
Targeting glutamine metabolism enhances responses to platinum-based chemotherapy in triple-negative breast cancers (TNBC)
Short communication | 更新时间:2022-11-09
    • Targeting glutamine metabolism enhances responses to platinum-based chemotherapy in triple-negative breast cancers (TNBC)

    • Targeting glutamine metabolism enhances responses to platinum-based chemotherapy in triple-negative breast cancers (TNBC)

    • Genes & Diseases   2022年9卷第6期
    • 作者机构:

      1. Sidney Kimmel Comprehensive Cancer Center and Department of Oncology, Baltimore,MD,USA,21231

      2. Department of Pathology, Johns Hopkins University School of Medicine, Baltimore,MD,USA,21231

      3. Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology,Hubei,Wuhan,PR China,430022

      4. Department of Gynecology and Obstetrics, Johns Hopkins University School of Medicine, Baltimore,MD,USA,21231

    • DOI:10.1016/j.gendis.2022.02.009    

      中图分类号:
    • 纸质出版日期:2022,

      网络出版日期:2022-11-1,

    扫 描 看 全 文

  • Targeting glutamine metabolism enhances responses to platinum-based chemotherapy in triple-negative breast cancers (TNBC)[J]. Genes & Diseases, 2022,9(6). DOI: 10.1016/j.gendis.2022.02.009.

    Jiaxin Hong, Yao-An Shen, Chih-Yi Hsu, et al. Targeting glutamine metabolism enhances responses to platinum-based chemotherapy in triple-negative breast cancers (TNBC)[J]. Genes & Diseases, 2022,9(6). DOI: 10.1016/j.gendis.2022.02.009.

  •  
  •  
查看原文

0

浏览量

0

下载量

0

CSCD

文章被引用时,请邮件提醒。
提交
工具集
下载
参考文献导出
分享
收藏
添加至我的专辑

相关文章

暂无数据

相关作者

暂无数据

相关机构

暂无数据
0